Population Assessment of Future Trajectories in Coronary Heart Disease Mortality
نویسندگان
چکیده
BACKGROUND Coronary heart disease (CHD) mortality rates have been decreasing in Iceland since the 1980s, largely reflecting improvements in cardiovascular risk factors. The purpose of this study was to predict future CHD mortality in Iceland based on potential risk factor trends. METHODS AND FINDINGS The previously validated IMPACT model was used to predict changes in CHD mortality between 2010 and 2040 among the projected population of Iceland aged 25-74. Calculations were based on combining: i) data on population numbers and projections (Statistics Iceland), ii) population risk factor levels and projections (Refine Reykjavik study), and iii) effectiveness of specific risk factor reductions (published meta-analyses). Projections for three contrasting scenarios were compared: (1) If the historical risk factor trends of past 30 years were to continue, the declining death rates of past decades would level off, reflecting population ageing. (2) If recent trends in risk factors (past 5 years) continue, this would result in a death rate increasing from 49 to 70 per 100,000. This would reflect a recent plateau in previously falling cholesterol levels and recent rapid increases in obesity and diabetes prevalence. 3) Assuming that in 2040 the entire population enjoys optimal risk factor levels observed in low risk cohorts, this would prevent almost all premature CHD deaths before 2040. CONCLUSIONS The potential increase in CHD deaths with recent trends in risk factor levels is alarming both for Iceland and probably for comparable Western populations. However, our results show considerable room for reducing CHD mortality. Achieving the best case scenario could eradicate premature CHD deaths by 2040. Public health policy interventions based on these predictions may provide a cost effective means of reducing CHD mortality in the future.
منابع مشابه
The value of troponin measurement in the prognosis of Covid 19 disease, a review study
Acute Respiratory Syndrome Coronavirus 2, which appeared in late 2019, can have negative effects on the cardiovascular system. Studies in different parts of the world indicate the importance of cardiac troponin as a predictor in coronary heart disease patients. Heart damage occurs frequently in Coronavirus 2 infection and is associated with a high risk of mortality in these patients. In people ...
متن کاملPrevalence of Rose Questionnaire Angina and its Association with Coronary Heart Disease Risk Factors in Tehran, IR.Iran
Background: Rose questionnaire is a standard mean for diagnosing angina pectoris in epidemiological study. The present study was done to determine the prevalence of angina pectoris according to Rose questionnaire for chest pain, and to investigate the association of angina with several coronary hearh disease risk factors in Tehran urban population (district-13) during 1999 to 2000. Methods: 60...
متن کاملRecognizing unrecognized risk: the evolving role of ventricular functional assessment in population-based studies.
The rapid evolution of advanced cardiac imaging technologies has resulted in enhanced detection of subclinical disease with the potential for early implementation of therapeutic strategies and reduction in subsequent morbidity and mortality. Noninvasive assessment of ventricular function can provide evidence of prevalent coronary artery disease and cardiomyopathy and could supplant electrocardi...
متن کاملریسک فاکتورهای مرگ بعد از عمل Coronary artery bypass graft بیمارستان امام، 78-1375
Introduction: Ischemic heart disease is the most common cause of mortality in developed countries. CABG (Coronary Artery Bypass Graft) is one of the therapeutic methods in ischemic heart disease. Methods and Materials: Considering the increased incidence of coronary artery disease in Iran, and with increased rate of CABG, we performed a cross sectioned study (1996-1999). In 635 patients 467 mal...
متن کاملAssessment of Anti-streptokinase Antibody in Patients with Heart Diseases and Normal Subjects
Background: Streptokinase, which is injected intravenously with a standard dose of 1.5 MIU, is the most widely used thrombolytic agent around the world. What is so important about this bioproduct is the level of antistreptokinase (anti-sk) antibody in the population, which is directly correlated to the incidence of streptococcal infections in that population. Objective: Since Iran is an endemic...
متن کامل